ERGOMED CLINICAL RESEARCH LIMITED
Get an alert when ERGOMED CLINICAL RESEARCH LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-03-05 (in 10mo)
Last made up 2026-02-19
Watchouts
Cash
£875K
+12.1% vs 2023
Net assets
£81K
-60.5% vs 2023
Employees
0
Average over period
Profit before tax
-£124K
-227.7% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
4 officer resignations in last 12 months
Multiple officers have left the board recently — see the People section for who.
Name history
Renamed 2 times since incorporation
- ERGOMED CLINICAL RESEARCH LIMITED 2014-06-06 → present
- ERGOMED CLINICAL LIMITED 2014-06-06 → 2014-06-06
- ERGOMED LIMITED 2004-04-05 → 2014-06-06
Net assets
2-year trend · vs Industrials median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £8,259,152 | £18,417,207 | |
| Operating profit | £96,796 | -£123,630 | |
| Profit before tax | £96,796 | -£123,636 | |
| Net profit | £96,796 | -£123,636 | |
| Cash | £780,584 | £874,758 | |
| Total assets less current liabilities | — | — | |
| Net assets | £204,348 | £80,712 | |
| Equity | £204,348 | £80,712 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 1.2% | -0.7% | |
| Net margin | 1.2% | -0.7% | |
| Current ratio | 1.11x | 1.08x | |
| Interest cover | — | -20605.00x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101 Reduced Disclosure Framework
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements have been prepared on the going concern basis, which assumes that the Company will have sufficient funds to continue in operational existence for the foreseeable future, being a period of no less than 12 months from the date of signing of the financial statements.”
Group structure
- ERGOMED CLINICAL RESEARCH LIMITED · parent
- Ergomed Pharmaceutical Services Inc. 100%
- Servicii Farmaceutice Ergomed S.r.l. 100%
- Ergomed Limited 100%
- Ergomed S.r.l. 100%
- Ergomed France SAS 100%
- Servicos Farmaceuticos PrimeVigilance, Unipessoal Lda. 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 16 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| JACKSON, Alaric Richard Warwick | Director | 2026-05-08 | Oct 1976 | British |
| JAVEED, Zubair | Director | 2025-12-19 | May 1972 | British |
| TONKOVIC RELJANOVIC, Gordana | Director | 2021-02-08 | Aug 1971 | Croatian |
Show 16 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BLETCHER, Joanne | Secretary | 2019-09-18 | 2025-12-31 |
| CARNEY, John | Secretary | 2004-10-25 | 2006-04-27 |
| JURIC, Sanja | Secretary | 2019-02-07 | 2019-09-18 |
| JURIC, Sanja | Secretary | 2004-05-06 | 2007-04-01 |
| CARGIL MANAGEMENT SERVICES LIMITED | Corporate Secretary | 2006-07-18 | 2010-10-14 |
| DEANS COURT REGISTRARS LIMITED | Corporate Secretary | 2004-04-06 | 2004-10-25 |
| TEMPLE SECRETARIES LIMITED | Corporate Nominee Secretary | 2004-04-05 | 2004-04-05 |
| BARFIELD, Richard Timothy | Director | 2019-07-08 | 2023-02-03 |
| CLARK, Neil Robert | Director | 2010-01-29 | 2017-04-14 |
| CURTAIN, Jonathan Andrew, Mr. | Director | 2023-02-03 | 2025-07-31 |
| JACKSON, Stuart Robert | Director | 2019-02-01 | 2019-07-08 |
| PRETORIUS, Sybrand Gerhardus | Director | 2024-08-21 | 2025-12-19 |
| RELJANOVIC, Miroslav | Director | 2004-04-06 | 2026-04-29 |
| SCHUTTE, Klemens | Director | 2005-04-11 | 2012-01-01 |
| STAMP, Stephen Anthony | Director | 2017-04-16 | 2019-02-01 |
| COMPANY DIRECTORS LIMITED | Corporate Nominee Director | 2004-04-05 | 2004-04-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Ergomed Group Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 105 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-11 | AP01 | officers | Appoint person director company with name date | |
| 2026-05-11 | TM01 | officers | Termination director company with name termination date | |
| 2026-03-04 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-01-05 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-12-23 | TM01 | officers | Termination director company with name termination date | |
| 2025-12-23 | AP01 | officers | Appoint person director company with name date | |
| 2025-10-29 | SH01 | capital | Capital allotment shares | |
| 2025-10-03 | AA | accounts | Accounts with accounts type full | |
| 2025-08-12 | TM01 | officers | Termination director company with name termination date | |
| 2025-03-05 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-05 | AA | accounts | Accounts with accounts type full | |
| 2024-08-22 | AP01 | officers | Appoint person director company with name date | |
| 2024-02-20 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-02-20 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-02-13 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-09-23 | AA | accounts | Accounts with accounts type full | |
| 2023-03-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-02-23 | AP01 | officers | Appoint person director company with name date | |
| 2023-02-06 | TM01 | officers | Termination director company with name termination date | |
| 2022-09-12 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 9
- Capital events
- 1
- Officers appointed
- 2
- Officers resigned
- 4
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+123%
£8,259,152 £18,417,207
-
Cash
+12.1%
£780,584 £874,758
-
Net assets
-60.5%
£204,348 £80,712
-
Employees
—
Not reported
-
Operating profit
-227.7%
£96,796 -£123,630
-
Profit before tax
-227.7%
£96,796 -£123,636
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers